For FTO, its expression level was positively correlated with CD8+ T cells, CD4+ T cells, macrophages and neutrophils, which suggested active anti-tumor microenvironment and might explain patients with higher transcription level of FTO possessed significant longer OS time (Figure 6I). The gene discussed is CD8A; the disease is neoplasm.